NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage
暂无分享,去创建一个
N. M. Lau | U. Surti | J. Engert | I. Touitou | R. Slim | J. Arseneau | C. Messaed | P. Coullin | C. Rittore | R. Bagga | W. Buckett | P. Sauthier | A. Cheung | J. Qian | L. Hoffner | W. Chebaro | Moy‐Fong Chen | R. B. Roberto | Ariel Schneider | Kurt Bernishke | Annie Cheung | Wafaa Chebaro
[1] Yimin Zhu,et al. The genetics of recurrent hydatidiform moles in China: correlations between NLRP7 mutations, molar genotypes and reproductive outcomes. , 2011, Molecular human reproduction.
[2] R. Slim,et al. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. , 2009, Human molecular genetics.
[3] R. Srinivasan,et al. A strong founder effect for two NLRP7 mutations in the Indian population: an intriguing observation , 2009, Clinical genetics.
[4] D. Bonthron,et al. Genetic and Epigenetic Analysis of Recurrent Hydatidiform Mole , 2009, Human mutation.
[5] P. Benos,et al. Homozygous NLRP7 mutations in a Moroccan woman with recurrent reproductive failure , 2009, Clinical Genetics.
[6] Hodges,et al. Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region , 2009, Journal of Medical Genetics.
[7] L. Shao,et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. , 2008, Molecular human reproduction.
[8] A. Martini,et al. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. , 2007, Arthritis and rheumatism.
[9] R. Slim,et al. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations , 2007, Human mutation.
[10] T. Rosenberg,et al. p.Gln200Glu, a putative constitutively active mutant of rod α‐transducin (GNAT1) in autosomal dominant congenital stationary night blindness , 2007, Human mutation.
[11] L. Horn,et al. Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles. , 2006, European journal of obstetrics, gynecology, and reproductive biology.
[12] R. Kuick,et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans , 2006, Nature Genetics.
[13] M. Wachtel. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. , 2005, The American journal of surgical pathology.
[14] Yetao Wang,et al. PYPAF3, a PYRIN-containing APAF-1-like Protein, Is a Feedback Regulator of Caspase-1-dependent Interleukin-1β Secretion* , 2005, Journal of Biological Chemistry.
[15] F. Martinon,et al. NALPs: a novel protein family involved in inflammation , 2003, Nature Reviews Molecular Cell Biology.
[16] N. Sebire,et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy , 2003, BJOG : an international journal of obstetrics and gynaecology.
[17] R. Mclellan,et al. Gestational trophoblastic disease. , 2001, Obstetrics and gynecology clinics of North America.
[18] Z. Lan,et al. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 patients. , 2001, Gynecologic oncology.
[19] S. J. Kim,et al. Subsequent reproductive experience after treatment for gestational trophoblastic disease. , 1998, Gynecologic oncology.
[20] R. Berkowitz,et al. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. , 1998, The Journal of reproductive medicine.
[21] C. Coulam. Epidemiology of Recurrent Spontaneous Abortion , 1991, American journal of reproductive immunology.
[22] C. la Vecchia,et al. Increased frequency of complete hydatidiform mole in women with repeated abortion. , 1988, Gynecologic oncology.
[23] C. la Vecchia,et al. Reproductive patterns and the risk of gestational trophoblastic disease. , 1985, American journal of obstetrics and gynecology.
[24] P. Sand,et al. Repeat Gestational Trophoblastic Disease , 1984, Obstetrics and gynecology.
[25] U. Surti,et al. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. , 1978, American journal of obstetrics and gynecology.
[26] U. Surti,et al. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. , 1978, American journal of obstetrics and gynecology.
[27] D. V. van Thiel,et al. Pregnancies after Chemotherapy of Trophoblastic Neoplasms , 1970, Science.
[28] Kronfol Nm,et al. Recurrent hydatidiform mole: a report of five cases with review of the literature. , 1969 .
[29] N. Kronfol,et al. Recurrent hydatidiform mole: a report of five cases with review of the literature. , 1969, Lebanese Medical Journal.